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Therapeutic lifestyle modification and aggressive lipid control are pivotal in reducing mortality in diabetic patients with atherosclerosis and their 
roles have been prominently emphasized in guidelines. However, it remains unknown if patients achieve therapeutic goal or achieve therapeutic 
life style modification.The purpose of our study was to determine how successfully therapeutic goal was achieved in outpatients with concomitant 
diabetes mellitus and atherosclerotic cardiovascular disease (ASCVD) and to evaluate weight changes over a 2 year period.
Method: The setting was an academic general cardiology practice with electronic medical record (EMR). We conducted a retrospective analysis 
of outpatients in the general cardiology practice with the diagnosis of diabetes mellitus plus documented ASCVD and had at least 2 clinic visits, 
6-months apart, between January 2008 and September 2009. EMR quarterly report cards were provided to providers in addition to regular 
educational conferences. Patients’ weights and BMI were closely followed. Values for lipoproteins, BP, BMI and weights were abstracted and analysed.
Results:  A total of 929 patients qualified for inclusion with mean age of 68.4 yrs, 51% males and 49% females. A high percentage received 
recommended therapy including ACEI/ARB (83.4%); anti-platelet (92%); beta blockers (75.7%) and statin (91%). Systolic BP < 130 mmHg was 
achieved by 61%. Mean LDL-C was 80 mg/dL and although 81% reached LDL-C < 100 mg/dL, only 41% achieved the recommended goal of < 70 
mg/dL. Mean BMI at last visit (32.1+ 9.4) was not different from initial visit (32.5 + 11.5). Among subjects with initial BMI < 30, as many as 19.2 
gained at least 5% of weight compared to 13.6% (BMI 30-35) and 10.5% (BMI>35) [p=.005]. By contrast, weight loss of at least 5% was similar 
among the 3 BMI classes: BMI < 30 (16.8%); BMI 30-35 (22.2%) and BMI> 35 (17.7), p=NS.
Conclusion: Many high risk patients with diabetes and ASCVD did receive recommended therapy; however, the percent of patients achieving 
therapeutic goals for LDL-C and SBP was modest. Performance on life style modification was poor with only a few losing weight and the most weight 
gains occurring among those with initial BMI< 30.
